{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:26:23Z","timestamp":1769729183057,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"International Atherosclerosis Society and Pfizer","award":["10839501"],"award-info":[{"award-number":["10839501"]}]},{"name":"International Atherosclerosis Society and Pfizer"},{"DOI":"10.13039\/501100001322","name":"Medical Research Council of South Africa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.atherosclerosis.2018.06.822","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T09:46:32Z","timestamp":1538127992000},"page":"470-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9700-6948","authenticated-orcid":false,"given":"Jing","family":"Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"David Marais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3965-5912","authenticated-orcid":false,"given":"Dirk J.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte C.","family":"Brice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0509-0880","authenticated-orcid":false,"given":"Pamela RS.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinthia E.","family":"Jannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre C.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2015.03.027","article-title":"Prevalence and treatment of familial hypercholesterolemia in Australian communities","volume":"185","author":"Watts","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States national health and nutrition examination surveys (NHANES)","volume":"133","author":"de Ferranti","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib3","first-page":"354","article-title":"Genetic identification of familial hypercholesterolemia within a single U.S. health care system","author":"Abul-Husn","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib4","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child\u2013parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpeds.2015.11.019","article-title":"Prevalence of familial hypercholesterolaemia in adolescents: potential value of universal screening?","volume":"170","author":"Pang","year":"2016","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib6","first-page":"34","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the international FH foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5551\/jat.34108","article-title":"International developments in the care of familial hypercholesterolemia: where now and where to next?","volume":"23","author":"Pang","year":"2016","journal-title":"J.\u00a0Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/eurheartj\/ehx136","article-title":"Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?","volume":"38","author":"Nordestgaard","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.5551\/jat.35949","article-title":"Translational research for improving the care of familial hypercholesterolemia: the \u201cten countries study\u201d and beyond","volume":"23","author":"Watts","year":"2016","journal-title":"J.\u00a0Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib11","first-page":"99","article-title":"Familial hypercholesterolaemia: the Cape Town experience","volume":"98","author":"Firth","year":"2008","journal-title":"S.\u00a0Afr. Med. J."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2014.12.036","article-title":"Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience","volume":"239","author":"Bell","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2014.11.009","article-title":"Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects","volume":"238","author":"Jannes","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib14","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib15","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jacl.2016.08.011","article-title":"Familial combined hyperlipidemia and hyperlipoprotein (a) as phenotypic mimics of familial hypercholesterolemia: frequencies, associations and predictions","volume":"10","author":"Ellis","year":"2016","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MOL.0000000000000325","article-title":"Diagnostic scoring for familial hypercholesterolaemia in practice","volume":"27","author":"Haralambos","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","article-title":"Genetic analysis of familial hypercholesterolaemia in Western Australia","volume":"224","author":"Hooper","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.281.6241.633","article-title":"A\u00a0host of hypercholesterolaemic homozygotes in South Africa","volume":"281","author":"Seftel","year":"1980","journal-title":"Br. Med. J."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(99)00470-0","article-title":"Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples?","volume":"148","author":"Miserez","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib21","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.ATV.0000177811.14176.2b","article-title":"Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation","volume":"25","author":"Civeira","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib22","first-page":"240","article-title":"Treatment gaps in adults with\u00a0heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH registry","author":"deGoma","year":"2016","journal-title":"Circulation: Cardiovascular Genetics"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib23","article-title":"Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992\u20132010","volume":"3","author":"Mundal","year":"2014","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish familial hypercholesterolemia longitudinal cohort study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib25","first-page":"65","article-title":"Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort","volume":"13","author":"Allard","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2014.02.021","article-title":"Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects","volume":"234","author":"B\u00e9liard","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.5551\/jat.14159","article-title":"Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan","volume":"19","author":"Harada-Shiba","year":"2012","journal-title":"J.\u00a0Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2009.09.014","article-title":"Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands","volume":"209","author":"Pijlman","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1258\/acb.2007.007078","article-title":"Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project","volume":"45","author":"Hadfield","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9149(00)01429-6","article-title":"Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia","volume":"87","author":"Hopkins","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2796.2003.01070.x","article-title":"Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia","volume":"253","author":"De Sauvage Nolting","year":"2003","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib33","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/hrt.2003.022764","article-title":"Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia","volume":"90","author":"Neil","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2007.12.024","article-title":"Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors","volume":"200","author":"Alonso","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.hlc.2016.09.012","article-title":"Increasing the detection of familial hypercholesterolaemia using general practice electronic databases","volume":"26","author":"Vickery","year":"2017","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib36","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib37","first-page":"1162","article-title":"Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol","author":"Thompson","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","article-title":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","volume":"201","author":"Chan","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.06.822_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.001","article-title":"Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration","volume":"22","author":"Vallejo-Vaz","year":"2016","journal-title":"Atherosclerosis Suppl."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018311353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018311353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:49:42Z","timestamp":1558630182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018311353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":39,"alternative-id":["S0021915018311353"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.822","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}